Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-20-005646)

Filing Details

Accession Number:: 0001493152-20-005646
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-04-01 21:24:57
Reporting Period:: 2020-03-30

Accepted Time:: 2020-04-01 21:24:57
Original Submission Date:: 2020-04-01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642380	Oncocyte Corp	OCX	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1299153	Asbury Ronald Andrews	15 Cushing Irvine CA 92618	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2020-03-30	27,216	$2.26	44,698	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2020-03-31	18,000	$2.37	62,698	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Amendment to correct March 31, 2020 share purchase price by replacing erroneous comma with a decimal point.